Uppsala, Sweden

Thomas Lundqvist

This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignees: Emplicure Ab, Diabact Ab, Orexo Ab. Active years: 2000-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Lundqvist. Retrieved from https://idiyas.com/inventor/thomas-lundqvist

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2000-2020

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Thomas Lundqvist: Innovator in Transdermal Drug Delivery Systems

Introduction

Thomas Lundqvist is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of drug delivery systems, particularly through his innovative transdermal drug administration devices. With a total of 4 patents to his name, Lundqvist continues to push the boundaries of pharmaceutical technology.

Latest Patents

Lundqvist's latest patents focus on a transdermal drug administration device. This device comprises a drug delivery element that defines a contact surface for placement against a patient's skin. The drug delivery element includes a sustained-release pharmaceutical composition. This composition consists of a network of a carrier material that possesses high mechanical strength, interspersed with an active pharmaceutical ingredient. The active ingredient is co-formedly integrated within the pores of the solid, continuous network of the carrier material.

Career Highlights

Throughout his career, Thomas Lundqvist has worked with various companies, including Emplicure AB and Diabact AB. His work has been instrumental in advancing drug delivery technologies, making medications more effective and easier to administer.

Collaborations

Lundqvist has collaborated with several professionals in his field, including Anders Pettersson and Håkan Engqvist. These collaborations have contributed to the development of innovative solutions in drug administration.

Conclusion

Thomas Lundqvist is a pioneering inventor whose work in transdermal drug delivery systems has the potential to transform patient care. His patents and collaborations reflect his commitment to advancing pharmaceutical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…